Cite
HARVARD Citation
Han, K. et al. (2022). Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses. Clinical pharmacology in drug development. 11 (10), pp. 1191-1202. [Online].